Hyaluronan Fragments: Informational Polymers Commandeered by Cancers

Hyaluronan in Cancer Biology

Volumn , Issue , 2009, Pages 221-254

  Sugahara, Kazuki N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84855594126     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012374178-3.10013-4     Document Type: Chapter

References (112)

1. Adams R.H., Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 2007, 8:464-478.
2. Ailles L.E., Weissman I.L. Cancer stem cells in solid tumors. Curr Opin Biotechnol 2007, 18:460-466.
3. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
4. Aruffo A., Stamenkovic I., Melnick M., Underhill C.B., Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990, 61:1303-1313.
5. Balazs E.A., Watson D., DuffI.F., Roseman S. Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritis human fluids. Arthritis Rheum 1967, 10:357-376.
6. Beck-Schimmer B., Oertli B., Pasch T., Wüthrich R.P. Hyaluronan induces monocyte chemoattractant protein-1 expression in renal tubular epithelial cells. J Am Soc Nephrol 1998, 9:2283-2290.
7. Blix G. Hyaluronic acid in the pleural and peritoneal fluids from a case of mesothelioma. Acta Soc Med Ups 1951, 56:47-50.
8. Chang E.J., Kim H.J., Ha J., et al. Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4. J Cell Sci 2007, 120:166-176.
9. Cordo Russo R.I., Garcia M.G., Alaniz L., et al. Hyaluronan oligosaccharides sensitize lymphoma resistant cell lines to vincristine by modulating P-glycoprotein activity and PI3K/Akt pathway. Int J Cancer 2008, 122:1012-1018.
10. Entwistle J., Hall C.L., Turley E.A. HA receptors: regulators of signalling to the cytoskeleton. J Cell Biochem 1996, 61:569-577.
11. Feinberg R.N., Beebe D.C. Hyaluronate in vasculogenesis. Science 1983, 220:1177-1179.
12. Fieber C., Baumann P., Vallon R., et al. Hyaluronan-oligosaccharide-induced transcription of metalloproteases. J Cell Sci 2004, 117:359-367.
13. Forteza R., Lieb T., Aoki T., et al. Hyaluronan serves a novel role in airway mucosal host defense. Faseb J 2001, 15:2179-2186.
14. Fujii K., Fujii Y., Hubscher S., Tanaka Y. CD44 is the physiological trigger of Fas up-regulation on rheumatoid synovial cells. J Immunol 2001, 167:1198-1203.
15. Ghatak S., Misra S., Toole B.P. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem 2002, 277:38013-38020.
16. Giraudo E., Inoue M., Hanahan D. An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest 2004, 114:623-633.
17. Grossfeld H. Production of hyaluronic acid in tissue culture of Rous sarcoma. Nature 1962, 196:782-783.
18. Hamilton S.R., Fard S.F., Paiwand F.F., et al. The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells. J Biol Chem 2007, 282:16667-16680.
19. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
20. Hardwick C., Hoare K., Owens R., et al. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol 1992, 117:1343-1350.
21. Hascall V.C., Heinegård D. Aggregation of cartilage proteoglycans. II. Oligosaccharide competitors of the proteoglycan-hyaluronic acid interaction. J Biol Chem 1974, 249:4242-4249.
22. Hodge-Dufour J., Noble P.W., Horton M.R., et al. Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages. J Immunol 1997, 159:2492-2500.
23. Hornof M., de la Fuente M., Hallikainen M., Tammi R.H., Urtti A. Low molecular weight hyaluronan shielding of DNA/PEI polyplexes facilitates CD44 receptor mediated uptake in human corneal epithelial cells. J Gene Med 2008, 10:70-80.
24. Horton M.R., McKee C.M., Bao C., et al. Hyaluronan fragments synergize with interferon-gamma to induce the C-X-C chemokines Mig and interferon-inducible protein-10 in mouse macrophages. J Biol Chem 1998, 273:35088-35094.
25. Horton M.R., Shapiro S., Bao C., Lowenstein C.J., Noble P.W. Induction and regulation of macrophage metalloelastase by hyaluronan fragments in mouse macrophages. J Immunol 1999, 162:4171-4176.
26. Horton M.R., Olman M.A., Bao C., et al. Regulation of plasminogen activator inhibitor-1 and urokinase by hyaluronan fragments in mouse macrophages. Am J Physiol Lung Cell Mol Physiol 2000, 279:L707-715.
27. Hosono K., Nishida Y., Knudson W., et al. Hyaluronan oligosaccharides inhibit tumorigenicity of osteosarcoma cell lines MG-63 and LM-8 in vitro and in vivo via perturbation of hyaluronan-rich pericellular matrix of the cells. Am J Pathol 2007, 171:274-286.
28. Huang B., Zhao J., Li H., et al. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 2005, 65:5009-5014.
29. Ibrahim S., Joddar B., Craps M., Ramamurthi A. A surface-tethered model to assess size-specific effects of hyaluronan (HA) on endothelial cells. Biomaterials 2007, 28:825-835.
30. Itano N., Sawai T., Miyaishi O., Kimata K. Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells. Cancer Res 1999, 59:2499-2504.
31. Itano N., Sawai T., Yoshida M., et al. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 1999, 274:25085-25092.
32. Itano N., Sawai T., Atsumi F., et al. Selective expression and functional characteristics of three mammalian hyaluronan synthases in oncogenic malignant transformation. J Biol Chem 2004, 279:18679-18687.
33. Jiang D., Liang J., Fan J., et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005, 11:1173-1179.
34. Jiang D., Liang J., Noble P.W. Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol 2007, 23:435-461.
35. Joddar B., Ramamurthi A. Fragment size- and dose-specific effects of hyaluronan on matrix synthesis by vascular smooth muscle cells. Biomaterials 2006, 27:2994-3004.
36. Kahmann J.D., O'Brien R., Werner J.M., et al. Localization and characterization of the hyaluronan-binding site on the link module from human TSG-6. Structure 2000, 8:763-774.
37. Kajita M., Itoh Y., Chiba T., et al. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 2001, 153:893-904.
38. Kanomata N., Yokose T., Kamijo T., et al. Hyaluronan synthase expression in pleural malignant mesotheliomas. Virchows Arch 2005, 446:246-250.
39. Kosaki R., Watanabe K., Yamaguchi Y. Overproduction of hyaluronan by expression of the hyaluronan synthase HAS-2 enhances anchorage-independent growth and tumorigenicity. Cancer Res 1999, 59:1141-1145.
40. Kothapalli D., Flowers J., Xu T., et al. Differential activation of ERK and Rac mediates the proliferative and anti-proliferative effects of hyaluronan and CD44. J Biol Chem 2008, 283:31823-31829.
41. Koyama H., Hibi T., Isogai Z., et al. Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M. Am J Pathol 2007, 170:1086-1099.
42. Koyama H., Kobayashi N., Harada M., et al. Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis: pivotal role of a hyaluronan-rich tumor microenvironment. Am J Pathol 2008, 172:179-193.
43. Kumar S., West D.C., Ponting J.M., Gattamaneni H.R. Sera of children with renal tumours contain low-molecular-mass hyaluronic acid. Int J Cancer 1989, 44:445-448.
44. Laurent T.C., Fraser J.R. Hyaluronan. Faseb J 1992, 6:2397-2404.
45. Lesley J., Hascall V.C., Tammi M., Hyman R. Hyaluronan binding by cell surface CD44. J Biol Chem 2000, 275:26967-26975.
46. Lokeshwar V.B., Öbek C., Soloway M.S., Block N.L. Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer. Cancer Res 1997, 57:773-777.
47. Lokeshwar V.B., Selzer M.G. Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells. J Biol Chem 2000, 275:27641-27649.
48. Lokeshwar V.B., Rubinowicz D., Schroeder G.L., et al. Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL-1 hyaluronidase in prostate cancer. J Biol Chem 2001, 276:11922-11932.
49. Lokeshwar V.B., Cerwinka W.H., Lokeshwar B.L. HYAL-1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion. Cancer Res 2005, 65:2243-2250.
50. Lokeshwar V.B., Selzer M.G. Urinary bladder tumor markers. Urol Oncol 2006, 24:528-537.
51. López-Otín C., Matrisian L.M. Emerging roles of proteases in tumour suppression. Nat. Rev Cancer 2007, 7:800-808.
52. Manzanares D., Monzon M.E., Savani R.C., Salathe M. Apical oxidative hyaluronan degradation stimulates airway ciliary beating via RHAMM and RON. Am J Respir Cell Mol Biol 2007, 37:160-168.
53. Marcante M.L. Properties of hyaluronic acid from a human myxosarcoma. Nature 1965, 208:896.
54. McCawley L.J., Matrisian L.M. Matrix metalloproteinases: they're not just for matrix anymore!. Curr Opin Cell Biol 2001, 13:534-540.
55. McKee, C.M., Penno, M.B., Cowman, M., et al. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest98, 2403-2413.
56. McKee C.M., Lowenstein C.J., Horton M.R., et al. Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor kappaB-dependent mechanism. J Biol Chem 1997, 272:8013-8018.
57. Meyer K., Palmer J.W. The polysaccharide of the vitreous humor. J Biol Chem 1934, 107:629-634.
58. Meyer K., Smyth E.M., Dawson M.H. The isolation of a mucopolysaccharide from synovial fluid. J Biol Chem 1939, 128:319-327.
59. Montesano R., Kumar S., Orci L., Pepper M.S. Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro. Lab Invest 1996, 75:249-262.
60. Nagano O., Murakami D., Hartmann D., et al. Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation. J Cell Biol 2004, 165:893-902.
61. Noble P.W., Lake F.R., Henson P.M., Riches D.W. Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages. J Clin Invest 1993, 91:2368-2377.
62. Noble P.W., McKee C.M., Cowman M., Shin H.S. Hyaluronan fragments activate an NF-kappa B/I-kappa B alpha autoregulatory loop in murine macrophages. J Exp Med 1996, 183:2373-2378.
63. Oertli B., Beck-Schimmer B., Fan X., Wüthrich R.P. Mechanisms of hyaluronan-induced up-regulation of ICAM-1 and VCAM-1 expression by murine kidney tubular epithelial cells: hyaluronan triggers cell adhesion molecule expression through a mechanism involving activation of nuclear factor-kappa B and activating protein-1. J Immunol 1998, 161:3431-3437.
64. Ohno S., Im H.J., Knudson C.B., Knudson W. Hyaluronan oligosaccharide-induced activation of transcription factors in bovine articular chondrocytes. Arthritis Rheum 2005, 52:800-809.
65. Ohno S., Im H.J., Knudson C.B., Knudson W. Hyaluronan oligosaccharides induce matrix metalloproteinase 13 via transcriptional activation of NFkappaB and p38 MAP kinase in articular chondrocytes. J Biol Chem 2006, 281:17952-17960.
66. Okamoto I., Kawano Y., Tsuiki H., et al. CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration. Oncogene 1999, 18:1435-1446.
67. Okamoto I., Kawano Y., Murakami D., et al. Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J Cell Biol 2001, 155:755-762.
68. Okamoto I., Tsuiki H., Kenyon L.C., et al. Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors. Am J Pathol 2002, 160:441-447.
69. Pahler J.C., Tazzyman S., Erez N., et al. Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response. Neoplasia 2008, 10:329-340.
70. Ragan C., Meyer K. The hyaluronic acid of synovial fluid in rheumatoid arthritis. J Clin. Invest 1949, 28:56-59.
71. Rahmanian M., Pertoft H., Kanda S., et al. Hyaluronan oligosaccharides induce tube formation of a brain endothelial cell line in vitro. Exp Cell Res 1997, 237:223-230.
72. Rockey D.C., Chung J.J., McKee C.M., Noble P.W. Stimulation of inducible nitric oxide synthase in rat liver by hyaluronan fragments. Hepatology 1998, 27:86-92.
73. Rodgers L.S., Lalani S., Hardy K.M., et al. Depolymerized hyaluronan induces vascular endothelial growth factor, a negative regulator of developmental epithelial-to-mesenchymal transformation. Circ Res 2006, 99:583-589.
74. Rooney P., Wang M., Kumar P., Kumar S. Angiogenic oligosaccharides of hyaluronan enhance the production of collagens by endothelial cells. J Cell Sci 1993, 105:213-218.
75. Sattar A., Rooney P., Kumar S., et al. Application of angiogenic oligosaccharides of hyaluronan increases blood vessel numbers in rat skin. J Invest Dermatol 1994, 103:576-579.
76. Schawalder A., Oertli B., Beck-Schimmer B., Wüthrich R.P. Regulation of hyaluronan-stimulated VCAM-1 expression in murine renal tubular epithelial cells. Nephrol Dial Transplant 1999, 14:2130-2136.
77. Scheibner K.A., Lutz M.A., Boodoo S., et al. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 2006, 177:1272-1281.
78. Seyfried N.T., McVey G.F., Almond A., et al. Expression and purification of functionally active hyaluronan-binding domains from human cartilage link protein, aggrecan and versican: formation of ternary complexes with defined hyaluronan oligosaccharides. J Biol Chem 2005, 280:5435-5448.
79. Slevin M., Krupinski J., Kumar S., Gaffney J. Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Lab Invest 1998, 78:987-1003.
80. Slevin M., Krupinski J., Gaffney J., et al. Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol 2007, 26:58-68.
81. Stern R. Hyaluronan catabolism: a new metabolic pathway. Eur J Cell Biol 2004, 83:317-325.
82. Stern R., Asari A.A., Sugahara K.N. Hyaluronan fragments: an information-rich system. Eur J Cell Biol 2006, 85:699-715.
83. Sugahara K.N., Hirata T., Murai T., Miyasaka M. Hyaluronan oligosaccharides and tumor progression. Trends Glycosci Glycotech 2004, 16:187-197.
84. Sugahara K.N., Murai T., Nishinakamura H., et al. Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells. J Biol Chem 2003, 278:32259-32265.
85. Sugahara K.N., Hirata T., Hayasaka H., et al. Tumor cells enhance their own CD44 cleavage and motility by generating hyaluronan fragments. J Biol Chem 2006, 281:5861-5868.
86. Sugahara K.N., Hirata T., Tanaka T., et al. Chondroitin sulfate E fragments enhance CD44 cleavage and CD44-dependent motility in tumor cells. Cancer Res 2008, 6:7191-7199.
87. Sun L.K., Beck-Schimmer B., Oertli B., Wüthrich R.P. Hyaluronan-induced cyclooxygenase-2 expression promotes thromboxane A2 production by renal cells. Kidney Int 2001, 59:190-196.
88. Takahashi Y., Li L., Kamiryo M., et al. Hyaluronan fragments induce endothelial cell differentiation in a CD44-and CXCL1/GRO1-dependent manner. J Biol Chem 2005, 280:24195-24204.
89. Takeda M., Ogino S., Umemoto R., et al. Ligand-induced structural changes of the CD44 hyaluronan-binding domain revealed by NMR. J Biol Chem 2006, 281:40089-40095.
90. Taylor K.R., Trowbridge J.M., Rudisill J.A., et al. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 2004, 279:17079-17084.
91. Taylor K.R., Yamasaki K., Radek K.A., et al. Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J Biol Chem 2007, 282:18265-18275.
92. Teder P., Vandivier R.W., Jiang D., et al. Resolution of lung inflammation by CD44. Science 2002, 296:155-158.
93. Termeer C., Benedix F., Sleeman J., et al. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002, 195:99-111.
94. Termeer C.C., Hennies J., Voith U., et al. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 2000, 165:1863-1870.
95. Tesar B.M., Jiang D., Liang J., et al. The role of hyaluronan degradation products as innate alloimmune agonists. Am J Transplant 2006, 6:2622-2635.
96. Thankamony S.P., Knudson W. Acylation of CD44 and its association with lipid rafts are required for receptor and hyaluronan endocytosis. J Biol Chem 2006, 281:34601-34609.
97. Tolg C., Hamilton S.R., Nakrieko K.A., et al. Rhamm-/- fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair. J Cell Biol 2006, 175:1017-1028.
98. Toole B.P., Gross J. The extracellular matrix of the regenerating newt limb: synthesis and removal of hyaluronate prior to differentiation. Dev Biol 1971, 25:57-77.
99. Toole B.P. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 2004, 4:528-539.
100. Truedsson E. A case of mesothelioma of the pleura and peritoneum producing hyaluronic acid. Acta Soc Med Ups 1951, 56:39-45.
101. Turley E.A., Noble P.W., Bourguignon L.Y. Signaling properties of hyaluronan receptors. J Biol Chem 2002, 277:4589-4592.
102. Voelcker V., Gebhardt C., Averbeck M., et al. Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4. Exp Dermatol 2008, 17:100-107.
103. Wang M.J., Kuo J.S., Lee W.W., et al. Translational event mediates differential production of tumor necrosis factor-alpha in hyaluronan-stimulated microglia and macrophages. J Neurochem 2006, 97:857-871.
104. West D.C., Hampson I.N., Arnold F., Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science 1985, 228:1324-1326.
105. West D.C., Kumar S. The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res 1989, 183:179-196.
106. Xu H., Ito T., Tawada A., et al. Effect of hyaluronan oligosaccharides on the expression of heat shock protein 72. J Biol Chem 2002, 277:17308-17314.
107. Xu H., Kurihara H., Ito T., et al. The keratan sulfate disaccharide Gal(6S03) beta1,4-GlcNAc(6S03) modulates interleukin 12 production by macrophages in murine Thy-1 type autoimmune disease. J Biol Chem 2005, 280:20879-20886.
108. Yabushita H., Noguchi M., Kishida T., et al. Hyaluronan synthase expression in ovarian cancer. Oncol Rep 2004, 12:739-743.
109. Yabushita H., Kishida T., Fusano K., et al. Role of hyaluronan and hyaluronan synthase in endometrial cancer. Oncol Rep 2005, 13:1101-1105.
110. Yamada Y., Itano N., Narimatsu H., et al. Elevated transcript level of hyaluronan synthase1 gene correlates with poor prognosis of human colon cancer. Clin Exp Metastasis 2004, 21:57-63.
111. Yoneda M., Suzuki S., Kimata K. Hyaluronic acid associated with the surfaces of cultured fibroblasts is linked to a serum-derived 85 kDa protein. J Biol Chem 1990, 265:5247-5257.
112. Zeng C., Toole B.P., Kinney S.D., Kuo J.W., Stamenkovic I. Inhibition of tumor growth in vivo by hyaluronan oligomers. Int J Cancer 1998, 77:396-401.